Roland Oetker - Evotec AG Insider

EVOTF -- USA Stock  

USD 19.65  2.17  12.41%

Deputy Chairman of the Supervisory Board
Mr. Roland Oetker was appointed as Deputy Chairman of the Supervisory Board of Evotec AG as of June 12 2013. Prior to that he was Member of the Supervisory Board of Evotec AG since June 16 2011. He is the Founder and Managing Director of ROI Verwaltungsgesellschaft mbH. He also serves as Honorary President of Deutsche Schutzvereinigung fuer Wertpapierbesitz e.V. Starting out as a lawyer in 1983. Mr. Oetker worked with the Deutsche Bank AG and was a CoChairman of the Managing Board of Massa AG. He was Member of the Supervisory Board of Deutsche Post AG since 2004 and of RheinischBergische Verlagsgesellschaft mbH since 2011
Age: 64  Chairman Since 2013      
49 40 5 60 81 0
Oetker was Member of the Board of Trustees of the RAG foundation since 2007. He had his professional training with Sal. Oppenheim jr. & Cie., Koeln, Schroder Banking Corporationrationration, New York and Lauter, Fischer & Partner, Koeln. Following his studies of economics and law in Saarbruecken and Muenster and passing his German bar exams he became a lawyer.

Management Efficiency

The company has return on total asset (ROA) of 4.3 % which means that it generated profit of $4.3 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 6.24 % meaning that it generated $6.24 on every $100 dollars invested by stockholders.
The company has accumulated 212.96 M in total debt with debt to equity ratio (D/E) of 53.8 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Evotec AG has Current Ratio of 0.72 indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.

Similar Executives

Entity Summary

Evotec AG provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. Evotec AG was founded in 1993 and is headquartered in Hamburg, Germany. Evotec AG operates under Drug Manufacturers - Specialty Generic classification in USA and traded on OTC Market. It employs 2178 people.Evotec AG (EVOTF) is traded on OTC Market in USA. It is located in Manfred Eigen Campus and employs 2,178 people.

Evotec AG Leadership Team

Werner Lanthaler, CEO
Claus Braestrup, Executive
Michael Shalmi, Executive, MBA
Mario Polywka, COO, Ph.D
Mary Tanner, Executive
Roland Oetker, Chairman
Andreas Pinkwart, Executive
Paul Herrling, Executive, Ph.D
Colin Bond, CFO, MBA
Cord Dohrmann, Executive
Iris LoewFriedrich, Executive, Ph.D
Bernd Hirsch, Executive
Enno Spillner, CFO
Elaine Sullivan, Executive
Wolfgang Plischke, Chairman, Ph.D

Stock Performance Indicators

Did you try this?

Run Idea Optimizer Now

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Idea Optimizer

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Evotec AG and U S Bancorp. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.